By Therapeutics
Oncology
Oncology drug development accounts for the largest share of the global new drug pipeline
U2XLab possesses extensive experience in PK, ADA, and biomarker analysis across diverse oncology modalities, including ADCs, immuno-oncology drugs, and cell therapies, supporting optimal decision-making throughout the entire drug development lifecycle
- Pharmacokinetics Analysis
- Anti-Drug Antibody Analysis
- Neutralizing Antibody Analysis
- Biomarker Analysis (Cytokine Profiling)
- ADC Pharmacokinetic (PK) Analysis
(Total Antibody, Drug-Conjugated Antibody & Free Payload Quantification) - Cytotoxicity Analysis (NK Cell / LDH Assay)
Immunology
Providing precise analytical services for immune response mechanisms and the efficacy and safety evaluation of immunotherapies
Comprehensive evaluation of cell-mediated and humoral immune responses across diverse immunological indications, including autoimmune diseases and allergies
- Immunogenicity Assessment (ADA / NAb)
- Cytokine Panel Analysis
- Immune Cell Phenotype Analysis (Lymphocyte subset)
- T Cell / B Cell Functional Analysis
- Immunotherapy PK Analysis
Metabolomics
Providing biomarker analysis services essential for the development of therapeutics for metabolic diseases such as obesity, diabetes, and fatty liver disease
Keeping pace with the rapid growth of metabolic pipelines, including GLP-1 receptor agonists, we support precise mass spectrometry-based metabolite quantification
- GLP-1 Class Drug PK Analysis
- Metabolic Biomarker Quantification Analysis
- Multiplex Cytokine / Chemokine Analysis
Vaccines & Infectious Diseases
Providing clinical trial sample analysis services for vaccines and therapeutics targeting viral and bacterial infectious diseases, including COVID-19, influenza, and tuberculosis.
Providing seamless one-stop support from PBMC isolation and cryopreservation to immune response evaluation, all safely conducted at U2XLab Biosafety Level 2 (BSL-2) lab.
- Immunogenicity Evaluation (IgG, IgA, IgM ELISA)
- Neutralizing Antibody (NAb) Analysis
- PBMC Isolation & Long-term Storage
- Lymphocyte Subtype Analysis
- Cytokine Secreting Cell Quantification (ELISpot)
- Viral Load Analysis (Viral Burden/Shedding)
Central Nervous System (CNS)
Providing highly sensitive analytical services specialized in clinical biomarker analysis for neurodegenerative diseases such as Alzheimer's and Parkinson's disease
Supporting CNS drug development by leveraging U2XLab's proven analytical capabilities, including CSF-based Amyloid-β42 analysis
- Pharmacokinetics (PK) Analysis
- CSF / Plasma Amyloid-β42 Quantification Analysis
- Neurodegeneration Biomarker Panel Analysis
- Immunogenicity & Cytokine Analysis
- High-sensitivity PK Analysis (LC-MS/MS)
